T-ALL
Clinical trials for T-ALL explained in plain language.
Never miss a new study
Get alerted when new T-ALL trials appear
Sign up with your email to follow new studies for T-ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Living Drug' trial seeks to reboot immune system to fight childhood leukemia
Disease control Recruiting nowThis study is testing a new type of treatment called CD123-CAR T-cell therapy for children and young adults (up to age 21) whose blood cancers have come back or haven't responded to other treatments. Doctors take a patient's own immune cells, modify them in a lab to better target…
Matched conditions: T-ALL
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for tough leukemia cases: antibody drug trial opens
Disease control Recruiting nowThis study is testing an antibody drug called isatuximab in adults whose T-cell acute lymphoblastic leukemia has returned or hasn't responded to standard treatments. It aims to see if adding this drug can help control the cancer and achieve remission. The trial will enroll 40 pat…
Matched conditions: T-ALL
Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC